Diabetic cataract-pathogenesis, epidemiology and treatment. Pollreisz A, Schmidt-Erfurth U. J Ophthalmol. 2010;2010:608751. doi: 10.1155/2010/608751. Epub 2010 Jun 17. PMID: 20634936
Laser refractive surgery in diabetic patients: a review of the literature. Spadea L, Paroli MP. Clin Ophthalmol. 2012;6:1775-83. doi: 10.2147/OPTH.S37384. Epub 2012 Nov 02. PMID: 23152656
Association of Alpha-Crystallin with Fiber Cell Plasma Membrane of the Eye Lens Accompanied by Light Scattering and Cataract Formation. Timsina R, Mainali L. Membranes (Basel). 2021 Jun 15;11(6). doi: 10.3390/membranes11060447. PMID: 34203836
The role of Toll-like receptors in retinal ischemic diseases. Xu WQ, Wang YS. Int J Ophthalmol. 2016 Sep 18;9(9):1343-51. doi: 10.18240/ijo.2016.09.19. eCollection 2016. PMID: 27672603
The Ontario printed educational message (OPEM) trial to narrow the evidence-practice gap with respect to prescribing practices of general and family physicians: a cluster randomized controlled trial, targeting the care of individuals with diabetes and hypertension in Ontario, Canada. Zwarenstein M, Hux JE, Kelsall D, Paterson M, Grimshaw J, Davis D, Laupacis A, Evans M, Austin PC, Slaughter PM, Shiller SK, Croxford R, Tu K. Implement Sci. 2007 Nov 26;2:37. doi: 10.1186/1748-5908-2-37. PMID: 18039361
The potential of nanomedicine therapies to treat neovascular disease in the retina. Farjo KM, Ma JX. J Angiogenes Res. 2010 Oct 08;2:21. doi: 10.1186/2040-2384-2-21. PMID: 20932321
Inflammation and diabetic retinal microvascular complications. Zhang W, Liu H, Al-Shabrawey M, Caldwell RW, Caldwell RB. J Cardiovasc Dis Res. 2011 Apr;2(2):96-103. doi: 10.4103/0975-3583.83035. PMID: 21814413
